Staar Surgical (STAA) announced the expiration of the 45-day “window shop” period under the terms of the previously announced merger agreement with affiliates of Alcon (ALC). The “window shop” period expired at 11:59 p.m., Eastern Time, on September 19 and no competing acquisition proposal was received despite Broadwood Partners’ active exploration of alternative buyers over the past 45 days.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on STAA:
- Yunqi Capital intends to vote against STAAR Surgical sale to Alcon
- Staar Surgical issues letter to stockholders regarding Alcon merger
- STAAR Surgical Announces Merger with Alcon
- Needham medtech & diagnostics analysts hold analyst/industry conference call
- Staar Surgical’s Merger Faces Hurdles: Stockholder Approval and Regulatory Challenges Loom